Rodger MA, Kahn SR, Cranney A, et al: Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J hromb Haemost 5:1600, 2007
Rodie VA, Thomson AJ, Stewart FM, et al: Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. BJOG 109:1020,t2002
Sabadell J, Casellas M, Alijotas-Reig J, et al: Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes. Eur J Obstet Gynecol Reprod Bioi 149:47, 2010
Saccone G, Berghella V, Maruotti GM, et al: Antiphospholipid antibody profile based obstetric outcomes of primary anti phospholipid syndrome: the PREGNANTS study. Am J Obstet GynecoIt216(5):525.e1, 2017
Saeed G, Moller M, Neuzner J, et al: Emergent surgical pulmonary embolectomy in a pregnant woman: case report and literature review. Tex Heart InstJ 41(2):188,t2014
Said JM, Higgins JR, Moses EK, et al: Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 115:5, 2010a Said JM, Ignjatovic V, Monagle PT, et al: Altered reference ranges for protein C and protein S during early pregnancy: implications for the diagnosis of protein C and protein S deficiency during pregnancy. Thromb Haemost 103:984,t2010b
Sanson BJ, Lensing A W, Prins MH, et al: Safety oflow-molecular-weight heparin in pregnancy: a systematic review. hromb Haemost 81 :668, 1999 Scarsbrook AF, Evans AL, Owen AR, et al: Diagnosis of suspected venous thromboembolic disease in pregnancy. Clin RadioIt61:1, 2006 Seguin J, Weatherstone K, Nankervis C: Inherited antithrombin III deficiency in the neonate. Arch Pediatr Adolesc Med 148:389, 1994
Seligsohn U, Lubetsky A: Genetic susceptibility to venous thrombosis. N Engl J Med 344:1222,t2001
Shanbhag S, Pai N, Ghosh K, et al: Letters to the editor. Prenatal diagnosis in a family with purpura fulminans. Blood Coagul Fibrinolysis 26:350,t2015
Sharpe CJ, Crowther A, Webert E, et al: Cerebral venous thrombosis during pregnancy in the setting of type I antithrombin deficiency: case report and literature review. TransfMed Rev 25:61,t2011
Sibai BM, Rouse OJ: Pharmacologic thromboprophylaxis in obstetrics: broader use demands better data. Obstet GynecoIt128(4):681, 2016
Silver vI, Saade GR, Thorsten V, et al: Factor V Leiden, prothrombin G20210A, and methylene tetrahydrofolate reductase mutations and stillbirth: the Stillbirth Collaborative Research Network. Am J Obstet Gynecol 215(4):468.e1,2016